1032 related articles for article (PubMed ID: 25897784)
21. Combined Pulmonary Fibrosis and Emphysema in Scleroderma-Related Lung Disease Has a Major Confounding Effect on Lung Physiology and Screening for Pulmonary Hypertension.
Antoniou KM; Margaritopoulos GA; Goh NS; Karagiannis K; Desai SR; Nicholson AG; Siafakas NM; Coghlan JG; Denton CP; Hansell DM; Wells AU
Arthritis Rheumatol; 2016 Apr; 68(4):1004-12. PubMed ID: 26636545
[TBL] [Abstract][Full Text] [Related]
22. Relationship between quantitative radiographic assessments of interstitial lung disease and physiological and clinical features of systemic sclerosis.
Tashkin DP; Volkmann ER; Tseng CH; Kim HJ; Goldin J; Clements P; Furst D; Khanna D; Kleerup E; Roth MD; Elashoff R
Ann Rheum Dis; 2016 Feb; 75(2):374-81. PubMed ID: 25452309
[TBL] [Abstract][Full Text] [Related]
23. Pulmonary membrane diffusing capacity and capillary blood volume measured during exercise from nitric oxide uptake.
Tamhane RM; Johnson RL; Hsia CC
Chest; 2001 Dec; 120(6):1850-6. PubMed ID: 11742912
[TBL] [Abstract][Full Text] [Related]
24. Combined measurement of carbon monoxide and nitric oxide lung transfer does not improve the identification of pulmonary hypertension in systemic sclerosis.
Degano B; Soumagne T; Delaye T; Berger P; Perez T; Guillien A; Pellegrin JL; Launay D; Magy-Bertrand N; Agard C; Tiev KP; Hua-Huy T; Tardiff C; Diaz V; Chambellan A; Dinh-Xuan AT
Eur Respir J; 2017 Oct; 50(4):. PubMed ID: 29051271
[TBL] [Abstract][Full Text] [Related]
25. Effect of mycophenolate mofetil on pulmonary function in scleroderma-associated interstitial lung disease.
Gerbino AJ; Goss CH; Molitor JA
Chest; 2008 Feb; 133(2):455-60. PubMed ID: 18071023
[TBL] [Abstract][Full Text] [Related]
26. Diffusing capacity for nitric oxide and carbon monoxide in patients with diffuse parenchymal lung disease and pulmonary arterial hypertension.
van der Lee I; Zanen P; Grutters JC; Snijder RJ; van den Bosch JMM
Chest; 2006 Feb; 129(2):378-383. PubMed ID: 16478855
[TBL] [Abstract][Full Text] [Related]
27. Comparison of different measures of diffusing capacity for carbon monoxide (DLCO) in systemic sclerosis.
Hudson M; Assayag D; Caron M; Fox BD; Hirsch A; Steele R; Gaudreau-Taillefer R; Tatibouet S; ; Rudski L; Baron M
Clin Rheumatol; 2013 Oct; 32(10):1467-74. PubMed ID: 23733274
[TBL] [Abstract][Full Text] [Related]
28. Performance of Forced Vital Capacity and Lung Diffusion Cutpoints for Associated Radiographic Interstitial Lung Disease in Systemic Sclerosis.
Showalter K; Hoffmann A; Rouleau G; Aaby D; Lee J; Richardson C; Dematte J; Agrawal R; Chang RW; Hinchcliff M
J Rheumatol; 2018 Nov; 45(11):1572-1576. PubMed ID: 30275265
[TBL] [Abstract][Full Text] [Related]
29. A study on pulmonary complications of systemic sclerosis in eastern India.
Ghosh A; Banerjee A; Biswas AK
Indian J Chest Dis Allied Sci; 2014; 56(4):231-5. PubMed ID: 25962196
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic value of exhaled nitric oxide to detect interstitial lung disease in systemic sclerosis.
Tiev KP; Coste J; Ziani M; Aubourg F; Cabane J; Dinh-Xuan AT
Sarcoidosis Vasc Diffuse Lung Dis; 2009 Jul; 26(1):32-8. PubMed ID: 19960786
[TBL] [Abstract][Full Text] [Related]
31. Impact of Systemic Sclerosis-Associated Interstitial Lung Disease With and Without Pulmonary Hypertension on Survival: A Large Cohort Study of the German Network for Systemic Sclerosis.
Moinzadeh P; Bonella F; Oberste M; Weliwitage J; Blank N; Riemekasten G; Müller-Ladner U; Henes J; Siegert E; Günther C; Kötter I; Pfeiffer C; Schmalzing M; Zeidler G; Korsten P; Susok L; Juche A; Worm M; Jandova I; Ehrchen J; Sunderkötter C; Keyßer G; Ramming A; Schmeiser T; Kreuter A; Lorenz HM; Hunzelmann N; Kreuter M
Chest; 2024 Jan; 165(1):132-145. PubMed ID: 37582424
[TBL] [Abstract][Full Text] [Related]
32. Prevalence and characteristics of moderate to severe pulmonary hypertension in systemic sclerosis with and without interstitial lung disease.
Launay D; Mouthon L; Hachulla E; Pagnoux C; de Groote P; Remy-Jardin M; Matran R; Lambert M; Queyrel V; Morell-Dubois S; Guillevin L; Hatron PY
J Rheumatol; 2007 May; 34(5):1005-11. PubMed ID: 17444586
[TBL] [Abstract][Full Text] [Related]
33. Mechanisms for reduced pulmonary diffusing capacity in haematopoietic stem-cell transplantation recipients.
Barisione G; Bacigalupo A; Brusasco C; Scanarotti C; Penco S; Bassi AM; Lamparelli T; Garlaschi A; Pellegrino R; Brusasco V
Respir Physiol Neurobiol; 2014 Apr; 194():54-61. PubMed ID: 24495442
[TBL] [Abstract][Full Text] [Related]
34. Body position, membrane diffusing capacity and pulmonary capillary blood volume in chronic bronchitis and pulmonary emphysema.
Chou KC; Chang SC; Chang HI; Shiao GM
Zhonghua Yi Xue Za Zhi (Taipei); 1999 Apr; 62(4):209-16. PubMed ID: 10367481
[TBL] [Abstract][Full Text] [Related]
35. [Single-breath and rebreathing methods for measurement of pulmonary diffusing function: a comparative study].
Liu QX; Zheng JP; Xie YQ; Guan WJ; Jiang CY; An JY; Yu XX; Liu WT; Gao Y
Zhonghua Jie He He Hu Xi Za Zhi; 2013 Jul; 36(7):510-5. PubMed ID: 24262087
[TBL] [Abstract][Full Text] [Related]
36. A prospective, longitudinal study evaluating the baseline six-minute walk test as an individual reference value in systemic sclerosis patients.
Vandecasteele E; Melsens K; De Keyser F; De Pauw M; Deschepper E; Decuman S; Piette Y; Thevissen K; Brusselle G; Smith V
Clin Exp Rheumatol; 2018; 36 Suppl 113(4):95-101. PubMed ID: 30183593
[TBL] [Abstract][Full Text] [Related]
37. Pulmonary function tests as outcomes for systemic sclerosis interstitial lung disease.
Caron M; Hoa S; Hudson M; Schwartzman K; Steele R
Eur Respir Rev; 2018 Jun; 27(148):. PubMed ID: 29769294
[TBL] [Abstract][Full Text] [Related]
38. Membrane and capillary blood components of diffusion capacity of the lung for carbon monoxide in pulmonary sarcoidosis: relation to exercise gas exchange.
Lamberto C; Nunes H; Le Toumelin P; Duperron F; Valeyre D; Clerici C
Chest; 2004 Jun; 125(6):2061-8. PubMed ID: 15189922
[TBL] [Abstract][Full Text] [Related]
39. Pericardial abnormalities predict the presence of echocardiographically defined pulmonary arterial hypertension in systemic sclerosis-related interstitial lung disease.
Fischer A; Misumi S; Curran-Everett D; Meehan RT; Ulrich SK; Swigris JJ; Frankel SK; Cosgrove GP; Lynch DA; Brown KK
Chest; 2007 Apr; 131(4):988-92. PubMed ID: 17426200
[TBL] [Abstract][Full Text] [Related]
40. [Change of pulmonary diffusing capacity, membrane diffusing capacity and pulmonary capillary blood volume in patients with COPD and connective tissue disease at rest and post-exercise].
Chi L; Liu Y; Piao Z
Zhonghua Jie He He Hu Xi Za Zhi; 1998 Jun; 21(6):344-7. PubMed ID: 11326890
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
